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Background: Argonaute genes are essential for RNA interference, stem cell maintenance and differentiation.
The Piwi-like genes, a subclass of the Argonaute genes, are expressed mainly in the germline. These genes
may be re-expressed in tumors, and expression of the Piwi-like genes is associated with prognosis in several
types of tumors.
Methods: We measured the expression of Piwi-like mRNAs (Piwi-like 2–4) in 125 soft tissue sarcoma (STS)
samples by qPCRs. Statistical tests were applied to study the correlation of expression levels with tumor-
specific survival for STS patients.
Results: In multivariate Cox’s regression analyses, we showed that low Piwi-like 2 and Piwi-like 4 mRNA
expression were significantly associated with a worse prognosis (RR = 1.87; p = 0.032 and RR = 1.82; p = 0.039).
Low expression of both genes was associated with a 2.58-fold increased risk of tumor-related death (p = 0.01).
Piwi-like 4 and combined Piwi-like 2 and 4 mRNA levels correlated significantly with prognosis (RR = 3.53;
p = 0.002 and RR = 5.23; p = 0.004) only for female but not for male patients. However, combined low Piwi-like
2 and 3 transcript levels were associated with worse survival (RR = 5.90; p = 0.02) for male patients.
Conclusions: In this study, we identified a significant association between the expression of Piwi-like 2 and 4
mRNAs and the tumor-specific survival of soft tissue sarcoma patients. Furthermore, a connection between sex
and the impact of Piwi-like mRNA expressions on STS patients’ prognosis was shown for the first time.Background
The Piwi (P-element-induced wimpy testis) family is a
subclass of the Argonaute gene/protein family character-
ized by their homology and the occurrence of PAZ and
Piwi domains [1,2]. PIWI proteins play important roles
in stem cell self-renewal, spermatogenesis, transposon
and RNA silencing, translational regulation, and chro-
matin remodeling in various organisms [3]. Cox and
coworkers identified the first Piwi gene in Drosophila
[4]. Piwi is required for the asymmetric division of
germ-line stem cells (GSCs) to produce and to maintain
a daughter GSC (stem cell self-renewal). In addition,
homologues of the Piwi gene have been identified in* Correspondence: helge.taubert@uk-erlangen.de
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reproduction in any medium, provided the orCaenorhabditis elegans, Arabidopsis and humans, but
not in bacteria or yeast, suggesting that Piwi has a stem
cell-related function existing only in multicellular organ-
isms. Piwi-like genes also play a role in adult somatic
stem cells, such as human hematopoietic stem cells and
mouse mesenchymal stem cells [5,6]. Four members of
the human Piwi gene family, Piwi-like 1 (Hiwi, Piwil1),
Piwi-like 2 (Hili, Piwil2), Piwi-like 3 (Piwil3) and Piwi-
like 4 (Hiwi2, Piwil4), have been described so far [7].
The genes have been mapped to different chromosomal
regions. Piwi-like 1 and Piwi-like 2 are located on
chromosome 12 (12q23-12q24.33) and chromosome 8
(8p21). Piwi-like 3 and Piwi-like 4 have been mapped to
chromosome 22 (22q11.2) and chromosome 11 (11q12).
An increasing number of publications have demon-
strated that members of the Piwi family may be re-
expressed in malignant tumors. Expression of these
genes may correlate with tumor behavior and patient
prognosis. Elevated protein expression of PIWIL1 isl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cancer, esophageal cancer and glioma [8-11]. PIWIL2
protein may be detected in various stages of cervical
squamous cell carcinoma and breast adenocarcinoma, as
well as in metaplastic epithelial cells and histologically
normal-appearing tissues adjacent to breast and cervical
tumors [12-14]. Additionally, high levels of PIWIL2,
PIWIL3 and PIWIL4 proteins are correlated with an ele-
vated risk of colon cancer [15]. Li and coworkers also
showed that increased PIWIL4 protein levels are signifi-
cantly associated with the risk of metastasis and progno-
sis in colon cancer patients [15].
Protein levels and mRNA levels are not necessarily
correlated [16]. Reasons for this could be different
mRNA stability, mRNA degradation, and posttranscrip-
tional regulation mechanisms. There are regulatory
layers of the transcriptome in which RNA-binding pro-
teins (RBPs), noncoding regulatory RNAs (ncRNAs) and
messenger RNAs (mRNAs) can interact [17].
However, there have been comparatively few studies
evaluating the impact of Piwi-like 1–4 mRNA expres-
sion in human cancers. In patients with gastric cancer
and soft tissue sarcoma (STS) and in male pancreatic
carcinoma patients, the levels of mRNA expression of
Piwi-like 1 are correlated with prognosis [9,18,19]. Ex-
pression of the Piwi-like 2 gene has been detected in
many different human tumors, including prostate,
breast, gastrointestinal, ovarian and endometrial cancers
[20]. However, no data have been published about Piwi-
like 3 and Piwi-like 4 mRNA expression levels in human
tumors. A search in the Oncomine database revealed an
expression of Piwi-like 3 in carcinomas of the breast,
colon, ovary and brain and for Piwi-like 4 in carcinomas
of the breast, liver and brain. In this study, we investi-
gated Piwi-like mRNA expression in patients with STS.
We attempted to correlate Piwi-like mRNA levels with
clinical factors such as tumor size and with tumor-
specific survival. We also performed a sex-specific ana-
lysis of the prognostic impact of Piwi-like mRNA ex-
pression in patients with STS.
Methods
Patients
In this study, tumor tissue samples of 125 patients with
STS were analyzed. All patients underwent surgical re-
section in the Department of Surgery, Martin-Luther-
University Halle-Wittenberg and the Department of
Surgery 1, University of Leipzig, Germany. The cohort
has been described in previous studies [21]. All diagno-
ses were verified by an experienced pathologist (HJH)
according to the UICC system. All patients gave written
informed consent. The study was approved by the Ethic
Committee of the Medical Faculty of the Martin-Luther-
University Halle-Wittenberg and it was performed incompliance with the Helsinki Declaration. Median pa-
tient age at the time of surgery was 58 years (range 14–
87 years). Median follow-up time was 32 months (range
2–201 months after primary tumor resection). Forty-nine
patients experienced locoregional recurrence, 10 patients
developed distant metastases and 61 patients died during
the observation time. All tumor samples were collected
before radio- or chemotherapy. For clinical and histo-
pathologic parameters, please refer to Table 1.
RNA isolation
Ten to twenty tumor tissue slices (30 μm) were used for
RNA isolation with Trizol reagent according to the man-
ufacturer’s protocol (Invitrogen, Karlsruhe, Germany).
Briefly, RNA was extracted with phenol/chloroform and
precipitated by isopropanol. Any remaining DNA traces
were removed by DNAse I digestion (Qiagen, Hilden,
Germany). The remaining pellet was washed twice in
ice-cold ethanol and resuspended in 30 μl of RNAse-free
water. RNA concentration was assessed with a Nano-
drop ND-1000 Spectrophotometer (Thermo Scientific,
Karlsruhe, Germany). RNA was stored at −80 °C.
cDNA synthesis
Two micrograms of RNA were used for cDNA synthesis.
cDNA was synthesized with the RevertAid H Minus
First strand cDNA Synthesis Kit according to the manu-
facturer’s protocol (Fermentas, St. Leon-Rot, Germany).
qPCR
Piwi-like gene expression was measured using TaqMan
Gene expression assays (Piwi-like 2: Hs01032719; Piwi-
like 3: Hs00908837; Piwi-like 4: Hs00895218) according
to the manufacturer’s protocol (Applied Biosystems,
Darmstadt, Germany). The recognition sites of primers
within the Piwi-like mRNAs are given in Additional file
1: Figure S1. Quantitative RT-PCR reactions were per-
formed with the HotStart-Taq Polymerase Kit (Qiagen,
Hilden, Germany) in a real-time cycler (LTF, Wasser-
burg; Germany). HPRT (hypoxanthine phosphoribosyl
transferase) expression was measured with the following
primers (HPRT fw: 5′-TTGCTGACCTGCTGGATTAC-
3′; rw: 5′-CTTGCG ACCTTGACCATCTT-3′) using
Maxima SYBR-Green qPCR Master Mix (Fermentas, St.
Leon-Rot, Germany) and served as reference gene. All
measurements were carried out from the same cDNA
aliquot within a short time period to ensure comparable
conditions. Gene expression was normalized to HPRT
mRNA expression. Quantification was performed using
self-established plasmid standards for Piwi-like 2, 3
and 4 and HPRT in the range of 104–108 copies/μl.
Relative mRNA expression ratios (copies of transcript
per fg HPRT) were used for subsequent statistical
analyses.
Table 1 The histopathologic, clinical and Piwi-like mRNA





Piwi-like 2 Piwi-like 3 Piwi-like 4
low high low high low high
Total 125 62 63 62 63 62 63
Sex
Male 57 29 28 26 31 27 30
Female 68 33 35 36 32 35 33
Histological subtype
LS 28 10 18 14 14 11 17
MFH 31 12 19 17 14 19 12
FS 7 4 3 5 2 3 4
RMS 8 5 3 2 6 5 3
LMS 21 14 7 9 12 9 12
NS 12 6 6 4 8 6 6
Syn 10 5 5 7 3 5 5
Other 8 6 2 4 4 4 4
Tumor size1
T1 29 17 12 10 19 18 11
T2 96 45 51 29 67 44 52
Tumor grade
I 19 7 12 7 12 5 14
II 58 30 28 29 29 31 27
III 48 25 23 26 22 26 22
Tumor stage
I 16 6 10 7 9 5 11
II 57 28 29 29 28 29 28
III 40 21 19 21 19 22 18
IV 12 7 5 5 7 6 6
Complete resection
Radical (R0) 87 44 43 44 43 42 45
Not radical (R1) 38 18 20 18 20 20 18
Location
Extremities 80 36 44 41 39 41 39
Trunk wall 12 9 3 8 4 6 6
Head/neck 4 2 2 1 3 4 0
Abdomen/
retroperitoneum
27 14 13 12 15 11 16
Multiple locations 2 1 1 0 2 0 2
Patient status
Alive 64 26 38 31 33 30 34
Dead 61 36 25 31 30 32 29
Abbreviations: No-number of cases, LS-liposarcoma, MFH-malignant fibrous
histiocytoma, FS-fibrosarcoma, RMS-rhabdomyosarcoma, LMS-leiomyosarcoma,
NS-neuronal sarcoma, Syn-synovial sarcoma.
1T1≤ 5 cm, T2> 5 cm.
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Bivariate correlation analyses were performed by Spear-
man rank correlations (rs). Kaplan-Meier and multivari-
ate Cox’s regression analyses were performed to analyze
the correlation of Piwi-like 2–4 mRNA expression levels
with tumor-specific survival. All statistical analyses were
conducted with PASW 18 software (IBM SPSS, Chicago,
IL, USA). P-values< 0.05 were considered significant.
Results
Expression of Piwi-like 2–4 mRNAs and their association
with clinical, histopathologic and molecular parameters
Piwi-like 2, Piwi-like 3 and Piwi-like 4 mRNA expression
levels were measured in tissue samples from 125 STS
patients. Cut-off values were set according to the me-
dian value for each gene (Piwi-like 2: 7.583 copies/fg
HPRT (range: 0.073–532.45), Piwi-like 3: 0.05 copies/
fg HPRT (range: 0–52.82) and Piwi-like 4: 1.754 copies/
fg HPRT (range: 0–22.89)).
In addition we studied the Piwi-like 2, Piwi-like 3 and
Piwi-like 4 mRNA expression levels in normal tissue
samples adjacent to tumor tissues from 22 out of the
125 STS patients. We detected median mRNA expres-
sion levels for Piwi-like 2: 0.5 copies/fg HPRT (range
0.04–24.84), for Piwi-like 3: 0.0 copies/fg HPRT (range
0–5), and for Piwi-like 4: 0.28 copies/fg HPRT (range 0–
39.5). The Piwi-like 2, Piwi-like 3 and Piwi-like 4 mRNA
expression levels are higher in the tumor tissues com-
pared to those in the normal tumor adjacent tissues. But
they are not correlated with each other (Spearman-Rho
test) and the median values of their differences are un-
equal (p< 0.05; Wilcoxon test).
We performed a bivariate linear correlation analysis
(Spearman-Rho-test) to examine whether the mRNA ex-
pression levels of individual Piwi-like genes were corre-
lated with the mRNA expression levels of the other
Piwi-like genes in the tumor tissues. The expression
levels of mRNA for Piwi-like 2 and Piwi-like 4 were
highly significantly correlated (rs = 0.36; p = 0.00003),
whereas no significant correlation was detected for ei-
ther mRNA with Piwi-like 3 in the tumor tissues.
Bivariate linear correlation analysis was also performed
to analyze the relationship of Piwi-like mRNA expres-
sion with clinical factors. The mRNA levels of all Piwi-
like genes studied were positively correlated to tumor
size (Piwi-like 2: rs = 0.21; p = 0.018; Piwi-like 3: rs = 0.20;
p = 0.024; and Piwi-like 4: rs = 0.18; p = 0.041), Next, we
investigated the correlation of Piwi-like 2–4 mRNAs
with other stem cell-associated genes (Nanog, Oct3/4
and survivin). Piwi-like 2 mRNA expression was in-
versely correlated with transcript levels of Oct3/4 and
Nanog in our STS cohort (rs =−0.31; p = 0.002 and rs =
−0.23; p = 0.029, respectively) but was positively corre-
lated with the splice variant 2B of the survivin gene (rs =
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negatively correlated with Nanog transcript levels (rs =
−0.24; p = 0.02). Piwi-like 4 mRNA levels were negatively
associated with the expression of the splice variant Delta
3 of the survivin gene (rs =−0.18; p = 0.047; Additional
file 2: Table S1).Association of the Piwi-like 2–4 mRNA expression level
with tumor-specific survival for all STS patients
Multivariate Cox’s regression analyses (adjusted for clin-
ical parameters including resection type, tumor stage,
tumor location and tumor type) were performed to
study the effect of the mRNA expression level of the
three Piwi-like genes on tumor-specific survival. For
Piwi-like 2, low mRNA expression was significantly asso-
ciated with a worse prognosis (RR = 1.87, 95% CI: 1.06–
3.32; p = 0.032). Low Piwi-like 4 mRNA expression also
correlated significantly with decreased tumor-specific
survival (RR = 1.82, 95% CI: 1.03–3.21; p = 0.039). Piwi-
like 3 expression was not significantly associated with
the prognosis of STS patients (RR = 1.33, 95% CI: 0.75–
2.3; p = 0.329).
Next, we studied the combined expression of the Piwi-
like 2 – 4 and their correlation with tumor-specific sur-
vival. Patients expressing low levels of either Piwi-like 2/
Piwi-like 3 or of Piwi-like 2/Piwi-like 4 had a signifi-
cantly increased risk of tumor-related death compared
with patients with a high expression level of the Piwi-like
mRNAs (RR= 2.10, 95% CI: 1.01–4.40; p = 0.048 andTable 2 Multivariate Cox’s regression analyses on the
impact of Piwi-like 2, -3 and −4 mRNA expression on STS
patients’ survival
Piwi-like 2 Piwi-like 3 Piwi-like 4
Relative risk (RR) 1.87 1.33 1.82
95% CI 1.06–3.32 0.75–2.3 1.03–3.21
p-value 0.032 0.329 0.039
n low 62 62 62
n high 63 63 63
Combination
Piwi-like 2 and −4
Combination
Piwi-like 2, -3 and −4
Relative risk (RR) 2.58 4.01
95% CI 1.26–5.29 1.61–10.01
p-value 0.01 0.003
n all low 39 21
n one gene elevated 46 43
n two genes elevated – 37
n all genes elevated 40 24
Significant p-values and relative risks are marked in bold face (p-values <0.05
were considered significant).RR= 2.58, 95% CI: 1.26–5.29; p = 0.01, respectively;
Table 2 ).
Association of the Piwi-like 2–4 mRNA expression level
with tumor-specific survival in a sex- specific manner for
STS patients
We performed separate analyses of the association of
Piwi-like 2–4 expression in male and female patients
(Additional file 3: Figure S2). Female patients with a low
level of Piwi-like 4 mRNA expression in their tumors
had a 3.53-fold significantly increased risk of tumor-
related death (95% CI: 1.56–8.0; p = 0.002). Furthermore,
in females, a trend for increased risk of tumor-related
death was seen in patients with low levels of Piwi-like 2
expression (RR = 1.88, 95% CI: 0.87–4.07). However, this
result was not statistically significant (p = 0.106). Male
patients with low levels of Piwi-like 2 or Piwi-like 3 had
a 2.76-fold and a 2.59-fold increased risk of tumor-
related death. However, this result was also not statisti-
cally significant (Table 3).
Finally, we analyzed the combined expression of the
Piwi-like 2–4 genes and their correlation with tumor-
specific survival in a sex-specific manner and observed
that different expression profiles were significantly cor-
related with survival in male and female patients. For
male patients, decreased expression of Piwi-like 2/
Piwi-like 3 was correlated with a 5.9-fold increase in
the risk of tumor-related death (95% CI: 1.33–26.23;
p = 0.02). In female patients, decreased Piwi-like 2/
Piwi-like 4 expression was correlated with a 5.23-fold
increase in the risk of tumor-related death (95% CI:
1.67–16.32; p = 0.004; Table 3 Figure 1). The results
revealed that the combined expression of Piwi-like genes
is correlated with tumor-specific survival in a sex-specific
manner.
Discussion
Previously we found that elevated levels of Piwi-like 1 in
STS and high as well as low levels of Piwi-like 1 in pancre-
atic adenocarcinomas were significantly associated with
worse patient’s survival. [18,19]. In our study, the levels of
Piwi-like 2–4 mRNA in STS were analyzed and correlated
with each other, with clinical and histopathologic para-
meters and with tumor-specific survival. We found a sig-
nificant correlation between tumor-specific survival and
Piwi-like 2 and Piwi-like 4 mRNA expression levels, but
not with Piwi-like 3 gene expression. There were correla-
tions between the mRNA expressions of the Piwi-like genes
and other stem cell-associated genes, such as Nanog, Oct3/
4 and survivin. Surprisingly, a low expression of Piwi-like 2
or Piwi-like 3 was significantly correlated with a high ex-
pression level of Nanog and Piwi-like-2 in addition with an
increased transcript level of Oct3/4, but with a decreased
level of the survivin 2B splice variant. Furthermore, low
B.
A.  
Figure 1 Multivariate Cox’s regression analyses: A. Combined expression of Piwi-like 2 and 3 in male STS patients and B. combined Piwi-like 2
and −4 expression in female STS patients and their correlation with tumor-specific survival.
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level of the survivin Delta 3 splice variant. However, the
survivin 2B splice variant is considered to be a pro-
apoptotic protein, whereas the survivin Delta 3 splice vari-
ant has an anti-apoptotic function [22]. PIWIL2 protein
may inhibit apoptosis via activation of Stat3/Bcl-X signaling
[20].
A somewhat surprising result of our study was that a low
mRNA expression level of all three Piwi-like genes was cor-
related with a poor prognosis, although higher protein
levels have been reported to be associated with a poorsurvival [8-11]. There are several possible explanations for
this phenomenon. Low mRNA transcription levels may
characterize more aggressive tumors. For example, low
mRNA levels for the oncogenes mdm2 and c-myc have
been correlated with a poor prognosis of patients with STS
and squamous carcinomas of the tongue, respectively
[23,24]. Another possibility is that there could be a negative
autoregulatory feedback loop between protein and RNA
levels in Piwi-like genes. Such a feedback loop has been
described for other genes, for example for Snail1. Snail1 is a
transcriptional repressor that binds to its own promoter
Table 3 Sex-specific association between Piwi-like 2–4 mRNA expression and STS patient survival
Female patients Male patients
Piwi-like 2 Piwi-like 3 Piwi-like 4 Piwi-like 2 Piwi-like 3 Piwi-like 4
Relative risk (RR) 1.88 1.13 3.53 2.76 2.59 1.10
95% CI 0.87–4.07 0.51–2.52 1.56–8.00 0.95–8.04 0.81–8.33 0.36–3.31
p-value 0.106 0.757 0.002 0.062 0.11 0.87
n low 34 34 34 28 28 28
n high 34 34 34 29 29 29
Combination
Piwi-like 2 and −4
Relative risk
(RR)
95% CI p-value Combination




n all low 22 5.23 1.67–16.32 0.004 15 5.90 1.33–26.23 0.02
n one gene elevated 24 4.47 1.47–13.61 0.008 26 2.84 0.77–10.41 0.12
n two genes elevated 22 reference 16 reference
Significant p-values and relative risks are marked in bold face (p-values <0.05 were considered significant).
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speculate that Piwi-like proteins, as the main effector
component of the RNA-induced silencing complex
(RISC), may regulate their own expression by post-
transcriptional gene silencing via an unknown small
RNA binding partner. Furthermore, different alternative
transcripts leading to shortened protein products of
PIWIL2 have been described recently [12]. The predom-
inant form, PL2L60, is mainly expressed in tumor cells
and promotes cell survival and proliferation of a human
breast cancer cell line (MDA-MB-231), possibly by the
upregulation of Bcl2 and Stat3. Because our primers tar-
geted the 5′ end of the different mRNA transcripts for
a better discrimination between the homologous genes,
we were not able to measure the shortened transcript.
Further studies are needed to determine if shortened al-
ternative mRNA transcripts and protein isoforms for
Piwi-like 3 and Piwi-like 4 also exist. Additionally,
shorter transcripts and/or their protein products could
decrease the levels of their full-length transcripts.
Piwi-like proteins bind exclusively to Piwi-interacting
RNA (piRNA), a class of small RNAs that differ structur-
ally from the classic siRNA and miRNA in several ways,
including length (24–30 nt instead of 18–23 nt), the car-
riage of a 2′O-methyl modification at the 3′ end and
their low conservation among even closely related spe-
cies [26-28]. piRNAs are transcribed from a limited set
of clusters located in pericentromeric or telomeric het-
erochromatic regions by an as yet unknown mechanism
[29]. Their maturation is involved in a set of degradation
steps involving transposon transcripts. Uncontrolled
transposon activation in Piwi gene mutants has been
observed in Drosophila and in mice [30,31], which
points to a role of Piwi-like genes in transposon control
during spermatogenesis. However, the mechanisms and
consequences of Piwi-like gene re-initiation in tumorsare not yet fully understood. Given our observation that
a low mRNA expression of Piwi-like genes is correlated
with increased tumor size and worse survival, one may
speculate that a decrease in the mRNA of Piwi-like
genes can derepress transposon activity and enhance
tumor cell selection to a more proliferative, active and
aggressive phenotype.
PIWI proteins appear to have sex-specific functions,
especially in vertebrate male germ cell maturation
[30-32]. We were able to show for the first time a
sex-specific effect of Piwi-like gene expression on the
survival of tumor patients. The presence of androgen
and estrogen receptors has been reported in soft tissue
sarcomas [33]. An in-silico search for binding sites for
sex-steroid receptors in the putative promoter regions
of the Piwi-like genes showed an androgen receptor
binding site in the Piwi-like 2 gene promoter (unpub-
lished results). However, the transcriptional activation
of the Piwi-like genes may also be initiated indirectly
by transcription factors regulated by sex-steroid bind-
ing factors. This question should be addressed in fur-
ther studies.
Conclusions
In conclusion, a correlation of Piwi-like 2–4 mRNA ex-
pression with tumor size and of Piwi-like 2 and Piwi-like
4 transcript levels with tumor-related death was found
for STS patients. Additionally, there was a sex-specific
association of the combination of low mRNA transcript
levels for Piwi-like 2/-3 and Piwi-like 2/-4 with tumor-
specific survival in male and in female STS patients, re-
spectively. A low mRNA expression level for Piwi-like
2–4 genes defines a significantly increased risk for
tumor-related death and may have potential as a pre-
dictor of survival for both all STS patients and in a sex-
specific manner.
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